Skip to main content

Table 1 Characteristics of patients (n = 682)

From: Cardiovascular disease events within 5 years after a diagnosis of breast cancer

 All patients
Patients (n)682
Clinical characteristics
 Gender (female)676 (99.12%)
 Age (mean years)62.5 (50.9–72.6)
 Body weight (mean kg ± SD)66.3 ± 13.6
 Body Mass Index (n = 662) (mean kg/m2 ± SD)25.5 ± 5.0
 Obesity107 (15.7%)
Cancer characteristics
 Breast side (left)357 (52.3%)
 UICC Breast Staging
  O39 (0.7%)
  I327 (47.9%)
  II226 (33.1%)
  III75 (11.0%)
  IV15 (2.2%)
 Histological type
  Infiltrating Ductal Carcinoma547 (80.2%)
  Infiltrating Lobular Carcinoma74 (10.9%)
  Carcinoma in situ39 (5.7%)
 Histopronostic criteria
  Her2 positive78 (11.4%)
  Hormonal receptors positives565 (82.8%)
  Triple negative58 (8.5%)
  SBR 1–2 grade454 (66.6%)
  SBR 3 grade191 (28.0%)
Cancer treatments
 Surgery665 (97.5%)
 Chemotherapy256 (37.5%)
 Trastuzumab therapy60 (8.8%)
 Radiotherapy673 (98.7%)
 Hormone blocking therapy551 (80.8%)
Cardiovascular characterics
 Cardiovascular risk factors340 (49.9%)
  Hypertension251 (73.8%)
  Diabetes mellitus59 (17.4%)
  Smoking (current or stopped less than 2 years)53 (15.6%)
  Hypercholesterolemia119 (35%)
Atrial fibrillation (AF) at cancer diagnosis22 (3.2%)
Cardiovascular treatments at cancer diagnosis214 (31.4%)
  Β-blockers71 (10.4%)
  ACE inhibitor or AIIRAs100 (14.7%)
  CCB63 (9.2%)
  Diuretics69 (10.1%)
  Anticoagulant20 (2.9%)
  One antiplatelet40 (5.9%)
  Dual antiplatelets3 (0.43%)